These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 2941075)

  • 1. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC; Tanaka Y
    Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin-binding and tissue plasminogen activator catalytic domains.
    Robbins KC; Boreisha IG
    Biochemistry; 1987 Jul; 26(15):4661-7. PubMed ID: 3117104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
    Lee PP; Wohl RC; Boreisha IG; Robbins KC
    Biochemistry; 1988 Sep; 27(19):7506-13. PubMed ID: 2974723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functionally active heavy chain derived from human high molecular weight urokinase.
    Sumi H; Robbins KC
    J Biol Chem; 1983 Jul; 258(13):8014-9. PubMed ID: 6345538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.
    Booyse FM; Lin PH; Traylor M; Bruce R
    J Biol Chem; 1988 Oct; 263(29):15139-45. PubMed ID: 3170576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Holmes WE; Collen D
    J Biol Chem; 1988 Apr; 263(12):5594-8. PubMed ID: 2965704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of activation of rabbit plasminogen by urokinase.
    Sodetz JM; Castellino FJ
    J Biol Chem; 1975 Apr; 250(8):3041-9. PubMed ID: 123529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
    Moroi M; Aoki N
    J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.
    Kasai S; Arimura H; Nishida M; Suyama T
    J Biol Chem; 1985 Oct; 260(22):12377-81. PubMed ID: 3930494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the urokinase-catalyzed activation of human plasminogen.
    Violand BN; Castellino FJ
    J Biol Chem; 1976 Jul; 251(13):3906-12. PubMed ID: 132442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala.
    Lijnen HR; Li XK; Nelles L; Hu MH; Collen D
    Eur J Biochem; 1992 Apr; 205(2):701-9. PubMed ID: 1533368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
    Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
    Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
    Harpel PC; Chang TS; Verderber E
    J Biol Chem; 1985 Apr; 260(7):4432-40. PubMed ID: 3156857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.